China Financial Statements From 2010 to 2025

000503 Stock   10.06  0.44  4.19%   
China Reform financial statements provide useful quarterly and yearly information to potential China Reform Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on China Reform financial statements helps investors assess China Reform's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting China Reform's valuation are summarized below:
China Reform Health does not presently have any fundamental signals for analysis.
Check China Reform financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China Reform's main balance sheet or income statement drivers, such as , as well as many indicators such as . China financial statements analysis is a perfect complement when working with China Reform Valuation or Volatility modules.
  
This module can also supplement various China Reform Technical models . Check out the analysis of China Reform Correlation against competitors.

China Reform Health Company Current Valuation Analysis

China Reform's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current China Reform Current Valuation

    
  8.82 B  
Most of China Reform's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Reform Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, China Reform Health has a Current Valuation of 8.82 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.

China Reform Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining China Reform's current stock value. Our valuation model uses many indicators to compare China Reform value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across China Reform competition to find correlations between indicators driving China Reform's intrinsic value. More Info.
China Reform Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value China Reform by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for China Reform's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About China Reform Financial Statements

China Reform stakeholders use historical fundamental indicators, such as China Reform's revenue or net income, to determine how well the company is positioned to perform in the future. Although China Reform investors may analyze each financial statement separately, they are all interrelated. For example, changes in China Reform's assets and liabilities are reflected in the revenues and expenses on China Reform's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in China Reform Health. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in China Stock

China Reform financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Reform security.